NEW YORK, April 03, 2018 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Akorn, Inc. (NASDAQ:AKRX) who purchased shares between March 1, 2017 and February 26, 2018. The action, which was filed in the United States District Court for the District of Illinois, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) the Company’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’ acquisition of the Company; (2) the Company lacked effective internal controls over financial reporting; and (3) as a result, the Company’s financial statements were materially false and misleading at all relevant times.
Shareholders have until May 7, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-c/akorn-inc?wire=3.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com


SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 



